Sidonie Golombowski-Daffner

Chairman & President at Advanced Accelerator Applications SA

Sidonie Golombowski-Daffner

Sidonie Golombowski-Daffner

Chairman & President at Advanced Accelerator Applications SA

Biography

Sidonie Roswitha Golombowski-Daffner is Co-Managing Director at Novartis Pharma Arzneimittel GmbH and Chairman & President at Advanced Accelerator Applications SA. She previously occupied the position of Chairman-Management Board at CIBA Vision GmbH (Germany).

Overview
Career Highlights

Advanced Accelerator Applications SA

RelSci Relationships

261

Number of Boards

2

Relationships
RelSci Relationships are individuals Sidonie Golombowski-Daffner likely has professional access to. A relationship does not necessarily indicate a personal connection.

General Manager Region Europe Oncology at Novartis Venture Fund

Relationship likelihood: Strong

Director at Abeona Therapeutics LLC

Relationship likelihood: Strong

President of Novartis Pharmaceuticals at Novartis AG

Relationship likelihood: Strong

Chief Financial Officer at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Head of Strategy & Operational Planning at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Chief Operations Officer at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Partner at Tre A SRL

Relationship likelihood: Strong

Chief Commercial Officer at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Head of Research & Business Development at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Former Chief Operating Officer at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Paths to Sidonie Golombowski-Daffner
Potential Connections via
Relationship Science
You
Sidonie Golombowski-Daffner
Chairman & President at Advanced Accelerator Applications SA
Career History
Chairman & President
2019 - Current

Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Saint Genis Pouilly, France.

Other Affiliations

Sidonie Golombowski-Daffner is affiliated with Advanced Accelerator Applications SA

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sidonie Golombowski-Daffner. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sidonie Golombowski-Daffner's profile does not indicate a business or promotional relationship of any kind between RelSci and Sidonie Golombowski-Daffner.